Annual Working Capital
$6.58 M
+$2.73 M+71.01%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual working capital is $6.58 million, with the most recent change of +$2.73 million (+71.01%) on December 31, 2023.
- During the last 3 years, ELTX annual working capital has fallen by -$5.56 million (-45.81%).
- ELTX annual working capital is now -45.81% below its all-time high of $12.15 million, reached on December 31, 2020.
Performance
ELTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$21.63 M
+$22.52 M+2513.62%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly working capital is $21.63 million, with the most recent change of +$22.52 million (+2513.62%) on September 30, 2024.
- Over the past year, ELTX quarterly working capital has increased by +$13.18 million (+156.08%).
- ELTX quarterly working capital is now at all-time high.
Performance
ELTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ELTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.0% | +156.1% |
| 3 y3 years | -45.8% | - |
| 5 y5 years | +19.5% | - |
ELTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +177.3% | at high | +2513.6% |
| 5 y | 5-year | -45.8% | +177.3% | at high | +2513.6% |
| alltime | all time | -45.8% | +177.3% | at high | +2513.6% |
Elicio Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.63 M(-2513.6%) |
| Jun 2024 | - | -$896.00 K(-111.0%) |
| Mar 2024 | - | $8.18 M(+24.3%) |
| Dec 2023 | $6.58 M | $6.58 M(-22.1%) |
| Sep 2023 | - | $8.45 M(-54.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $18.63 M(+384.0%) |
| Dec 2022 | $3.85 M(-145.2%) | $3.85 M(-66.6%) |
| Dec 2021 | -$8.52 M(-170.1%) | - |
| Mar 2021 | - | $11.51 M |
| Dec 2020 | $12.15 M(+120.6%) | - |
| Dec 2019 | $5.51 M | - |
FAQ
- What is Elicio Therapeutics annual working capital?
- What is the all time high annual working capital for Elicio Therapeutics?
- What is Elicio Therapeutics annual working capital year-on-year change?
- What is Elicio Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly working capital year-on-year change?
What is Elicio Therapeutics annual working capital?
The current annual working capital of ELTX is $6.58 M
What is the all time high annual working capital for Elicio Therapeutics?
Elicio Therapeutics all-time high annual working capital is $12.15 M
What is Elicio Therapeutics annual working capital year-on-year change?
Over the past year, ELTX annual working capital has changed by +$2.73 M (+71.01%)
What is Elicio Therapeutics quarterly working capital?
The current quarterly working capital of ELTX is $21.63 M
What is the all time high quarterly working capital for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly working capital is $21.63 M
What is Elicio Therapeutics quarterly working capital year-on-year change?
Over the past year, ELTX quarterly working capital has changed by +$13.18 M (+156.08%)